GSK Plans New Global R&D Centre at Cambridge Biomedical Campus
GSK is set to establish a 300,000 sqft global research and development (R&D) centre at Cambridge Biomedical Campus as part of a wider £400 million investment, with Prologis appointed as development partner for the new life sciences facility.
AstraZeneca Moves Low-Carbon Inhaler Closer to EU Approval
AstraZeneca has received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) for Trixeo Aerosphere using a next-generation propellant with near-zero Global Warming Potential (GWP). The decision supports the company's plans to reduce the carbon footprint of its respiratory medicines while maintaining treatment for patients with chronic obstructive pulmonary disease (COPD).
Philips Future Health Index 2026: AI Reshapes Frontline Care in the UK as Healthcare Readiness Gaps Remain
Philips’ Future Health Index 2026 report finds artificial intelligence (AI) is already helping UK healthcare professionals save time, increase patient capacity and support clinical decision-making, but highlights ongoing challenges around training, governance and workplace readiness.
Johnson & Johnson to Invest More Than USD$1 Billion in U.S. Vision Manufacturing Expansion in Jacksonville, Florida
Johnson & Johnson is investing more than USD$1 billion to expand its Jacksonville Vision manufacturing operations, adding advanced production, packaging, and distribution capacity to strengthen U.S. supply chain resilience and support demand for ACUVUE® contact lenses used by more than 40 million patients globally.
DHL’s Automated Healthcare Hub Signals the Future of UK Life Sciences Supply Chains
DHL Supply Chain is investing in a new automated healthcare logistics hub at Infinity Park Derby, combining shared-user warehousing, multi-temperature capabilities and sustainability-led design. The facility reflects how healthcare supply chains are evolving to meet growing demand for pharmaceuticals, medical devices and consumer health products through greater resilience, scalability and automation.
Haleon Expands Rural Health Access in India with £175 Million Manufacturing and Distribution Investment
New Haleon manufacturing facility and expanded community outreach aim to improve oral health access for more than 300 million additional consumers.
Eli Lilly Expands North America Indiana Manufacturing Investment with Genetic Medicine Facility
Eli Lilly and Company is expanding its domestic pharmaceutical manufacturing footprint with an additional $4.5 billion investment across its Lebanon, Indiana, production sites, while also opening its first dedicated genetic medicine manufacturing facility.
Can a Smart Watch Predict Fainting? Samsung Study Demonstrates Preventative Healthcare Tech Solution
A clinical study conducted by Samsung and Chung-Ang University Gwangmyeong Hospital has demonstrated the potential for consumer wearables to predict vasovagal syncope episodes before they occur, signalling new opportunities for preventive monitoring and digital health intervention.
Colgate-Palmolive Unveils 2030 Sustainability Strategy to Drive Growth and Impact
Colgate-Palmolive has launched its 2030 Sustainability & Social Impact Strategy, outlining a five-year roadmap focused on delivering measurable environmental and social outcomes while supporting long-term business resilience and growth.
AWS Launches Amazon Bio Discovery to Accelerate AI-Driven Drug Research
AWS has launched Amazon Bio Discovery, a new AI-powered application designed to help life sciences researchers accelerate drug discovery by combining biological foundation models, agentic AI and integrated lab testing workflows.
